BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 27212100)

  • 21. Structure-function relationships for the EGF/TGF-alpha family of mitogens.
    Groenen LC; Nice EC; Burgess AW
    Growth Factors; 1994; 11(4):235-57. PubMed ID: 7779404
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The epidermal growth factor receptor (EGFR)-S442F mutant displays increased affinity for neuregulin-2beta and agonist-independent coupling with downstream signalling events.
    Gilmore JL; Gallo RM; Riese DJ
    Biochem J; 2006 May; 396(1):79-88. PubMed ID: 16445385
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In silico design: extended molecular dynamic simulations of a new series of dually acting inhibitors against EGFR and HER2.
    Ahmed M; Sadek MM; Abouzid KA; Wang F
    J Mol Graph Model; 2013 Jul; 44():220-31. PubMed ID: 23911931
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single-molecule analysis of epidermal growth factor binding on the surface of living cells.
    Teramura Y; Ichinose J; Takagi H; Nishida K; Yanagida T; Sako Y
    EMBO J; 2006 Sep; 25(18):4215-22. PubMed ID: 16946702
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Structure of the extracellular region of HER3 reveals an interdomain tether.
    Cho HS; Leahy DJ
    Science; 2002 Aug; 297(5585):1330-3. PubMed ID: 12154198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A model for the activation of the epidermal growth factor receptor kinase involvement of an asymmetric dimer?
    Groenen LC; Walker F; Burgess AW; Treutlein HR
    Biochemistry; 1997 Apr; 36(13):3826-36. PubMed ID: 9092812
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cumulative effect of double-site mutations of human epidermal growth factor on receptor binding.
    Campion SR; Geck MK; Niyogi SK
    J Biol Chem; 1993 Jan; 268(3):1742-8. PubMed ID: 8380576
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidermal growth factor (EGF) receptor ligands in the chicken ovary: I. Evidence for heparin-binding EGF-like growth factor (HB-EGF) as a potential oocyte-derived signal to control granulosa cell proliferation and HB-EGF and kit ligand expression.
    Wang Y; Li J; Ying Wang C; Yan Kwok AH; Leung FC
    Endocrinology; 2007 Jul; 148(7):3426-40. PubMed ID: 17395697
    [TBL] [Abstract][Full Text] [Related]  

  • 29. pH dependence of ligand-induced human epidermal growth factor receptor activation investigated by molecular dynamics simulations.
    Dong J; Zhang Y; Zhang Z
    J Mol Model; 2016 Jun; 22(6):131. PubMed ID: 27179806
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Affinity enhancement of nanobody binding to EGFR: in silico site-directed mutagenesis and molecular dynamics simulation approaches.
    Farasat A; Rahbarizadeh F; Hosseinzadeh G; Sajjadi S; Kamali M; Keihan AH
    J Biomol Struct Dyn; 2017 Jun; 35(8):1710-1728. PubMed ID: 27691399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the nature of low- and high-affinity EGF receptors on living cells.
    Ozcan F; Klein P; Lemmon MA; Lax I; Schlessinger J
    Proc Natl Acad Sci U S A; 2006 Apr; 103(15):5735-40. PubMed ID: 16571657
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Toward a Novel Drug To Target the EGF-EGFR Interaction: Design of Metabolically Stable Bicyclic Peptides.
    Guardiola S; Seco J; Varese M; Díaz-Lobo M; García J; Teixidó M; Nevola L; Giralt E
    Chembiochem; 2018 Jan; 19(1):76-84. PubMed ID: 29105934
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Thermodynamic mixing of molecular states of the epidermal growth factor receptor modulates macroscopic ligand binding affinity.
    Holbrook MR; Slakey LL; Gross DJ
    Biochem J; 2000 Nov; 352 Pt 1(Pt 1):99-108. PubMed ID: 11062062
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Directed evolution of the epidermal growth factor receptor extracellular domain for expression in yeast.
    Kim YS; Bhandari R; Cochran JR; Kuriyan J; Wittrup KD
    Proteins; 2006 Mar; 62(4):1026-35. PubMed ID: 16355407
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling the epidermal growth factor -- epidermal growth factor receptor l2 domain interaction: implications for the ligand binding process.
    Jorissen RN; Treutlein HR; Epa VC; Burgess AW
    J Biomol Struct Dyn; 2002 Jun; 19(6):961-72. PubMed ID: 12023799
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Growth hormone alters epidermal growth factor receptor binding affinity via activation of extracellular signal-regulated kinases in 3T3-F442A cells.
    Huang Y; Chang Y; Wang X; Jiang J; Frank SJ
    Endocrinology; 2004 Jul; 145(7):3297-306. PubMed ID: 15070853
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Modification of a receptor-binding surface of epidermal growth factor (EGF): analogs with enhanced receptor affinity at low pH or at neutrality.
    Mullenbach GT; Chiu CY; Gyenes A; Blaney J; Rosenberg S; Marlowe CK; Brown S; Stratton-Thomas J; Montelione GT; George-Nascimento C; Stauber G
    Protein Eng; 1998 Jun; 11(6):473-80. PubMed ID: 9725626
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Homology models of the mutated EGFR and their response towards quinazoline analogues.
    Kotra S; Madala KK; Jamil K
    J Mol Graph Model; 2008 Oct; 27(3):244-54. PubMed ID: 18585943
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Two EGF molecules contribute additively to stabilization of the EGFR dimer.
    Lemmon MA; Bu Z; Ladbury JE; Zhou M; Pinchasi D; Lax I; Engelman DM; Schlessinger J
    EMBO J; 1997 Jan; 16(2):281-94. PubMed ID: 9029149
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Creation and biophysical characterization of a high-affinity, monomeric EGF receptor ectodomain using fluorescent proteins.
    Kozer N; Henderson C; Bailey MF; Rothacker J; Nice EC; Burgess AW; Clayton AH
    Biochemistry; 2010 Sep; 49(35):7459-66. PubMed ID: 20715761
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.